Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001525878-11-000320
Filing Date
2011-11-21
Accepted
2011-11-21 16:28:10
Documents
9
Period of Report
2011-08-31

Document Format Files

Seq Description Document Type Size
1 global-biotechcorp.htm 10-Q/A 317975
2 ex31-1.htm EX-31.1 17835
3 ex32-1.htm EX-32.1 8661
  Complete submission text file 0001525878-11-000320.txt   903305

Data Files

Seq Description Document Type Size
4 gbiq-20110831.xml EX-101.INS 44925
5 gbiq-20110831.xsd EX-101.SCH 13388
6 gbiq-20110831_cal.xml EX-101.CAL 6299
7 gbiq-20110831_def.xml EX-101.DEF 6027
8 gbiq-20110831_lab.xml EX-101.LAB 70661
9 gbiq-20110831_pre.xml EX-101.PRE 50961
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-Q/A | Act: 34 | File No.: 000-33271 | Film No.: 111219302
SIC: 7389 Services-Business Services, NEC